FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897864627> ?p ?o ?g. }

• W2897864627 endingPage "162.e1" @default.
• W2897864627 startingPage "156" @default.
• W2897864627 abstract "•Statins are a mainstay therapy for the prevention of atherosclerotic cardiovascular disease. •In this study, we characterized the predictors of statin use among adults aged ≥65 years. •More than 2 in 5 of older adults were dispensed statins in a calendar year. •Individual-level factors such as age, sex, and comorbidities predicted statin use. Background Statins comprise a key strategy for the prevention and treatment of arteriosclerotic cardiovascular disease, but prescribing remains suboptimal. Objectives The objective of this study was to characterize the predictors of statin use among adults aged ≥65 years. Methods A cross-sectional study using Pharmaceutical Benefits Scheme (PBS) data on reimbursed prescriptions for a 10% random sample of the Australian population in 2016 was performed. Predictors of statin use were identified via multivariable logistic regression. Analyses were performed separately for people who were concessional beneficiaries (with a low, capped copayment) and other (“general”) people. Results Among 351,471 (concessional = 295,875 and general = 55,596) older adults, 44.2% were dispensed statins (concessional = 46.4% and general = 32.2%). Among the concessional beneficiaries, people aged 75 to 84 years were more likely to use statins (odds ratio [OR] 1.08, 95% confidence interval [CI] 1.06–1.10), whereas those aged ≥85 years were less likely to use statins (OR 0.71, 95% CI 0.69–0.72), compared with people aged 65 to 74 years. Men were more likely to use statins than women (OR 1.14, 95% CI 1.12–1.16). Diabetes was associated with over 2-fold (OR 2.48, 95% CI 2.43–2.53) increased likelihood of statin use. People with cardiovascular-related conditions including hypertension, angina, and congestive heart failure experienced increased likelihood of statin use as was being dispensed anticoagulant or antiplatelet medication. Having malignancy, psychotic illness, or pain were associated with lower likelihood of statin use. Similar predictors of statin use were noted for the general population. Conclusion More than 40% of older adults in Australia used statins in 2016 with uptake dependent on individual-level factors such as demographics and comorbidities. Future research should examine the extent to which provider and/or health system–level factors contribute to the variable uptake of statin therapy. Statins comprise a key strategy for the prevention and treatment of arteriosclerotic cardiovascular disease, but prescribing remains suboptimal. The objective of this study was to characterize the predictors of statin use among adults aged ≥65 years. A cross-sectional study using Pharmaceutical Benefits Scheme (PBS) data on reimbursed prescriptions for a 10% random sample of the Australian population in 2016 was performed. Predictors of statin use were identified via multivariable logistic regression. Analyses were performed separately for people who were concessional beneficiaries (with a low, capped copayment) and other (“general”) people. Among 351,471 (concessional = 295,875 and general = 55,596) older adults, 44.2% were dispensed statins (concessional = 46.4% and general = 32.2%). Among the concessional beneficiaries, people aged 75 to 84 years were more likely to use statins (odds ratio [OR] 1.08, 95% confidence interval [CI] 1.06–1.10), whereas those aged ≥85 years were less likely to use statins (OR 0.71, 95% CI 0.69–0.72), compared with people aged 65 to 74 years. Men were more likely to use statins than women (OR 1.14, 95% CI 1.12–1.16). Diabetes was associated with over 2-fold (OR 2.48, 95% CI 2.43–2.53) increased likelihood of statin use. People with cardiovascular-related conditions including hypertension, angina, and congestive heart failure experienced increased likelihood of statin use as was being dispensed anticoagulant or antiplatelet medication. Having malignancy, psychotic illness, or pain were associated with lower likelihood of statin use. Similar predictors of statin use were noted for the general population. More than 40% of older adults in Australia used statins in 2016 with uptake dependent on individual-level factors such as demographics and comorbidities. Future research should examine the extent to which provider and/or health system–level factors contribute to the variable uptake of statin therapy." @default.
• W2897864627 created "2018-10-26" @default.
• W2897864627 creator A5012008190 @default.
• W2897864627 creator A5017249382 @default.
• W2897864627 creator A5024051019 @default.
• W2897864627 creator A5033053622 @default.
• W2897864627 creator A5049467468 @default.
• W2897864627 creator A5078028015 @default.
• W2897864627 creator A5079437838 @default.
• W2897864627 date "2019-01-01" @default.
• W2897864627 modified "2023-10-16" @default.
• W2897864627 title "Predictors of statin use among older adults: A nationwide cross-sectional study" @default.
• W2897864627 cites W1224944581 @default.
• W2897864627 cites W133203387 @default.
• W2897864627 cites W1483043653 @default.
• W2897864627 cites W1560686237 @default.
• W2897864627 cites W1898025493 @default.
• W2897864627 cites W2013685236 @default.
• W2897864627 cites W2028121853 @default.
• W2897864627 cites W2046039931 @default.
• W2897864627 cites W2084794697 @default.
• W2897864627 cites W2097092357 @default.
• W2897864627 cites W2109929144 @default.
• W2897864627 cites W2124509076 @default.
• W2897864627 cites W2132279603 @default.
• W2897864627 cites W2135930722 @default.
• W2897864627 cites W2139224873 @default.
• W2897864627 cites W2142194547 @default.
• W2897864627 cites W2149351396 @default.
• W2897864627 cites W2153058204 @default.
• W2897864627 cites W2157494695 @default.
• W2897864627 cites W2160544378 @default.
• W2897864627 cites W2162980141 @default.
• W2897864627 cites W2163932483 @default.
• W2897864627 cites W2171541729 @default.
• W2897864627 cites W2338109770 @default.
• W2897864627 cites W2346623028 @default.
• W2897864627 cites W2413538055 @default.
• W2897864627 cites W2460492626 @default.
• W2897864627 cites W2468188540 @default.
• W2897864627 cites W2552558094 @default.
• W2897864627 cites W2554191060 @default.
• W2897864627 cites W2556188414 @default.
• W2897864627 cites W2597938872 @default.
• W2897864627 cites W2600024674 @default.
• W2897864627 cites W2756863454 @default.
• W2897864627 cites W2786243773 @default.
• W2897864627 cites W2788963474 @default.
• W2897864627 cites W2791781475 @default.
• W2897864627 cites W2799670590 @default.
• W2897864627 doi "https://doi.org/10.1016/j.jacl.2018.10.002" @default.
• W2897864627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30446321" @default.
• W2897864627 hasPublicationYear "2019" @default.
• W2897864627 type Work @default.
• W2897864627 sameAs 2897864627 @default.
• W2897864627 citedByCount "6" @default.
• W2897864627 countsByYear W28978646272019 @default.
• W2897864627 countsByYear W28978646272021 @default.
• W2897864627 crossrefType "journal-article" @default.
• W2897864627 hasAuthorship W2897864627A5012008190 @default.
• W2897864627 hasAuthorship W2897864627A5017249382 @default.
• W2897864627 hasAuthorship W2897864627A5024051019 @default.
• W2897864627 hasAuthorship W2897864627A5033053622 @default.
• W2897864627 hasAuthorship W2897864627A5049467468 @default.
• W2897864627 hasAuthorship W2897864627A5078028015 @default.
• W2897864627 hasAuthorship W2897864627A5079437838 @default.
• W2897864627 hasBestOaLocation W28978646272 @default.
• W2897864627 hasConcept C126322002 @default.
• W2897864627 hasConcept C134018914 @default.
• W2897864627 hasConcept C142052008 @default.
• W2897864627 hasConcept C142724271 @default.
• W2897864627 hasConcept C151956035 @default.
• W2897864627 hasConcept C156957248 @default.
• W2897864627 hasConcept C2426938 @default.
• W2897864627 hasConcept C2776839432 @default.
• W2897864627 hasConcept C2778793514 @default.
• W2897864627 hasConcept C2908647359 @default.
• W2897864627 hasConcept C36434225 @default.
• W2897864627 hasConcept C44249647 @default.
• W2897864627 hasConcept C555293320 @default.
• W2897864627 hasConcept C71924100 @default.
• W2897864627 hasConcept C98274493 @default.
• W2897864627 hasConcept C99454951 @default.
• W2897864627 hasConceptScore W2897864627C126322002 @default.
• W2897864627 hasConceptScore W2897864627C134018914 @default.
• W2897864627 hasConceptScore W2897864627C142052008 @default.
• W2897864627 hasConceptScore W2897864627C142724271 @default.
• W2897864627 hasConceptScore W2897864627C151956035 @default.
• W2897864627 hasConceptScore W2897864627C156957248 @default.
• W2897864627 hasConceptScore W2897864627C2426938 @default.
• W2897864627 hasConceptScore W2897864627C2776839432 @default.
• W2897864627 hasConceptScore W2897864627C2778793514 @default.
• W2897864627 hasConceptScore W2897864627C2908647359 @default.
• W2897864627 hasConceptScore W2897864627C36434225 @default.
• W2897864627 hasConceptScore W2897864627C44249647 @default.
• W2897864627 hasConceptScore W2897864627C555293320 @default.
• W2897864627 hasConceptScore W2897864627C71924100 @default.
• W2897864627 hasConceptScore W2897864627C98274493 @default.

• next